Other News To Note
Horizon Discovery Ltd., of Cambridge, UK, said it is collaborating with the Rosalind Franklin University of Medical Sciences to develop a human cellular disease model of cystic fibrosis. The agreement focuses on the use of Horizon's GENESIS precision genome editing technology to reconstitute a specific mutation in the cystic fibrosis transmembrane conductance regulatory protein.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST